Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Swine Vaccines Market

Swine Vaccines Market Share

Report ID: GMI10445
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Swine Vaccines Market Share

The market is characterized by a competitive landscape with several key players vying for market share. Companies such as Zoetis Inc., Boehringer Ingelheim International GmbH, Elanco, and Merck & Co., Inc. are prominent in the market, leveraging extensive R&D investments to develop advanced vaccines. These companies focus on expanding their product portfolios to address a wide range of swine diseases, including Porcine Reproductive and Respiratory Syndrome (PRRS), Swine Influenza, and Foot-and-Mouth Disease (FMD).

Swine Vaccines Market Companies

Prominent players operating in the swine vaccines industry include:

Biogenesis Bago
Bioveta, a.s.
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Elanco Animal Health Incorporated
HIPRA
Indian Immunologicals Limited
Merck & Co., Inc.
Phibro Animal Health Corporation
Vaxxinova
Virbac
Zoetis Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global swine vaccines industry was valued at USD 1.6 billion in 2023 and is anticipated to record a CAGR of 5.3% through 2032, backed by the increasing prevalence of swine diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus Type 2 (PCV2), and African Swine Fever (ASF).

The inactivated vaccines segment accounted for USD 568.4 million in 2023, owing to their proven track record in preventing swine diseases, along with fewer side effects and adverse reactions, leading to widespread acceptance and trust among farmers and veterinarians.

In 2023, North America market was valued at USD 633.6 million and is expected to record a CAGR of 5.1% from 2024 to 2032, backed by the advanced veterinary infrastructure, supporting efficient vaccine distribution, administration, and monitoring, ensuring high vaccination coverage and effectiveness.

Ceva Sante Animale, Elanco Animal Health Incorporated, HIPRA, Indian Immunologicals Limited, Merck & Co., Inc., Phibro Animal Health Corporation, Vaxxinova, Virbac, and Zoetis Inc. among others.